Top Life Sciences Analytics startups
There are 1,280 Life Sciences Analytics startups which include Innovaccer, PathAI, Cellworks, Truveta, Basecamp Research. Out of these, 497 startups are funded, with 208 having secured Series A+ funding. United States has the most number of companies in Life Sciences Analytics (509), followed by United Kingdom
(97), and then Germany (73).
2026 has seen the creation of 6 Life Sciences Analytics startups. Over the past 10 years, an average of 54 new companies have been launched annually. Notably, several of these startups have been founded by alumni of Stanford University, Harvard University and University of Cambridge.
Here is the list of top Life Sciences Analytics Startups

1. Innovaccer
Developer of healthcare data platforms and artificial intelligence agent software. This technology unifies clinical, operational, and financial information from disparate systems to support decision-making. The platform provides tools for population health management, revenue cycle automation, and quality performance tracking. It enables the deployment of automated assistants to streamline administrative workflows, manage patient outreach, and facilitate care coordination across various healthcare settings. The system integrates non-electronic health record data to improve documentation accuracy and support value-based care initiatives.
Key facts about Innovaccer
- Founded Year: 2014
- Location: San Francisco (United States)
- Stage: Series F
- Total Funding till date: $675M
- Investors: WestBridge Capital, Mubadala and 36 Others
- Latest Funding Round: Series F, Jan 09, 2025, $*****
- Tracxn Score: 78/100 What is this?
- Competitors Rank: 3 of 994 Competitors

2. PathAI
Provider of digital pathology image management system for clinical labs. It offers an AISight is a cloud-native intelligent enterprise workflow solution used by the laboratories and research centers to power their digital pathology workflows and AI applications. It serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable multiple histopathology use cases.
Key facts about PathAI
- Founded Year: 2016
- Location: Boston (United States)
- Stage: Series C
- Total Funding till date: $255M
- Investors: General Catalyst, General Atlantic and 22 Others
- Latest Funding Round: Series C, May 18, 2021, $*****
- Tracxn Score: 71/100 What is this?
- Competitors Rank: 1 of 284 Competitors
3. Cellworks
Developer of a biosimulation platform. It has developed a biosimulation platform that uses computational modeling and offers the life science industry a framework for designing therapeutics to transform entirely empirical drug development. The platform is used for predicting responses to FDA-approved cancer therapies, & provides personalized cancer therapy recommendations.
Key facts about Cellworks
- Founded Year: 2005
- Location: San Jose (United States)
- Stage: Series B
- Total Funding till date: $16.5M
- Investors: Bering Capital, Artiman and 3 Others
- Latest Funding Round: Series B, Dec 26, 2012, $*****
- Tracxn Score: 66/100 What is this?
- Competitors Rank: 1 of 136 Competitors

4. Truveta
Key facts about Truveta
- Founded Year: 2020
- Location: Seattle (United States)
- Stage: Series C
- Total Funding till date: $515M
- Investors: CommonSpirit, Trinity Health and 7 Others
- Latest Funding Round: Series C, Jan 13, 2025, $*****
- Tracxn Score: 65/100 What is this?
- Competitors Rank: 3 of 1,003 Competitors
Biotechnology company using AI to explore undiscovered biology for applications in pharma, food, and industry These models utilize large-scale genetic datasets to generate protein sequences for medical applications. The technology enables the creation of genetic medicines and therapeutic agents by applying computational analysis to evolutionary biological data. This approach facilitates the design of molecules for various disease areas and biological functions.
Key facts about Basecamp Research
- Founded Year: 2019
- Location: London (United Kingdom)
- Stage: Series C
- Total Funding till date: $85M
- Investors: Valo Health, Hummingbird Ventures and 22 Others
- Latest Funding Round: Series C, Sep 23, 2026, $*****
- Tracxn Score: 64/100 What is this?
- Competitors Rank: 1 of 79 Competitors
